Assembly Biosciences Inc (ASMB)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

331 OYSTER POINT BLVD. SOUTH SAN FRANCISCO, CA 94080

Ventrus Biosciences, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of late-stage prescription drugs for gastrointestinal disorders primarily hemorrhoids, anal fissures, and fecal incontinence.

Data as of 2021-05-08 11:02:27 -0400
Market Cap163.042 Million Shares Outstanding40.158 Million Avg 30-day Volume830.027 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-1.27 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.17626 52-week High/Low27.84 / 3.84 Next Earnings Date2021-08-04 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from ASMB instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 1 100.0% 1 (0.06%) 0 (0.0%)
Funds Holding: 111 120 -7.5% 41 (2.46%) 49 (3.05%) -16.33%
13F shares: 27.112 Million 30.492 Million -11.08% 16.318 Million 18.823 Million -13.31%
% Ownership 82.1015 92.3367 -11.08% 49.4144 57.001 -13.31%
New Positions: 28 22 27.27% 12 14 -14.29%
Increased Positions 39 32 21.88% 14 13 7.69%
Closed Positions 37 10 270.0% 20 3 566.67%
Reduced Positions 25 44 -43.18% 11 18 -38.89%
Total Calls 112.618 Thousand 46.646 Thousand 141.43% 40.8 Thousand 45.6 Thousand -10.53%
Total Puts 27.076 Thousand 0 21 Thousand
PUT/CALL Ratio 0.24 0.0 0.51 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ASMB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ASMB BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MCHUTCHISON JOHN G CEO AND PRESIDENT

  • Officer
  • Director
305,000 2021-03-29 2

RUSSO THOMAS JOSEPH CFO

  • Officer
122,133 2021-03-29 1

STAMM LUISA M CHIEF MEDICAL OFFICER

  • Officer
86,353 2021-03-29 2

OKAZAKI JASON A CHIEF LEGAL & BUSINESS OFFICER

  • Officer
149,750 2021-03-29 1

DELANEY WILLIAM E IV CHIEF SCIENTIFIC OFFICER

  • Officer
123,750 2021-03-29 3

PAPKOFF JACQUELINE SYBIL SVP-CSO MICROBIOME

  • Officer
37,364 2020-12-14 1

CONSYLMAN GINA

  • Director
0 2020-10-19 2

HOLUBIAK MYRON Z

  • Director
0 2020-06-11 1

ALTIG ANTHONY E

  • Director
0 2020-06-11 1

DIMARCHI RICHARD D

  • Director
0 2020-06-11 1

LEWIS ALAN

  • Director
0 2020-06-11 1

MAHONY SUSAN

  • Director
0 2020-06-11 1

KIM HELEN SUSAN

  • Director
0 2020-06-11 1

COLONNO RICHARD JAMES EVP & CSO, VIROLOGY OPS

  • Officer
137,009 2020-03-27 0

RINGO WILLIAM R

  • Director
17,465 2020-02-28 0

SMALL DEREK A

  • Director
828,791 2020-01-02 0

SAMAR MICHAEL P. SVP, FINANCE AND BUS. OPS, PAO

  • Officer
20,327 2019-10-01 0

AUERBACH MARK

  • Director
0 2019-05-17 0

LOPATIN URI A CHIEF MEDICAL OFFICER

  • Officer
632,361 2019-03-29 0

COOPER GRAHAM K SEE REMARKS

  • Officer
117,500 2019-03-29 0

ECOR1 CAPITAL FUND QUALIFIED, L.P.

  • 10% Owner
0 2018-04-17 0

ROLLINS THOMAS E CHIEF DEVELOPMENT OFFICER

  • Officer
3,750 2018-03-29 0

BARRETT DAVID JONATHAN SEE REMARKS

  • Officer
0 2017-03-29 0

BARBOSA MIGUEL SEE REMARKS

  • Officer
0 2016-10-06 0

ARNOLD LEE D CHIEF SCIENTIFIC OFFICER

  • Officer
0 2014-07-11 0

ELLISON RUSSELL H

  • Director
21,600 2014-07-10 0

ZLOTNICK ADAM

  • 10% Owner
1,321,009 2014-07-10 0

FELDER JOSEPH

  • Director
0 2013-03-06 0

ROWLAND THOMAS ANDREW CHIEF BUSINESS OFFICER

  • Officer
18,387 2012-01-15 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MCHUTCHISON JOHN G - Director - Officer CEO AND PRESIDENT

2021-04-02 16:35:27 -0400 2021-03-29 A 305,000 a 305,000 direct

DELANEY WILLIAM E IV - Officer CHIEF SCIENTIFIC OFFICER

2021-04-02 16:47:56 -0400 2021-03-29 A 67,500 a 67,500 direct

STAMM LUISA M - Officer CHIEF MEDICAL OFFICER

2021-04-02 16:44:55 -0400 2021-03-29 A 11,250 a 18,853 direct -0.4435 -5.5432 0.0 1 -5.5432 6

OKAZAKI JASON A - Officer CHIEF LEGAL & BUSINESS OFFICER

2021-04-02 16:39:25 -0400 2021-03-29 A 82,500 a 82,500 direct

DELANEY WILLIAM E IV - Officer CHIEF SCIENTIFIC OFFICER

2021-04-02 16:47:56 -0400 2021-03-29 A 11,250 a 56,250 direct -0.4435 -5.5432 0.0 1 -5.5432 6

RUSSO THOMAS JOSEPH - Officer CFO

2021-04-02 16:41:57 -0400 2021-03-29 A 67,500 a 67,500 direct

OKAZAKI JASON A - Officer CHIEF LEGAL & BUSINESS OFFICER

2021-04-02 16:39:25 -0400 2021-03-29 A 13,750 a 67,250 direct -0.4435 -5.5432 0.0 1 -5.5432 6

STAMM LUISA M - Officer CHIEF MEDICAL OFFICER

2021-04-02 16:44:55 -0400 2021-03-29 A 67,500 a 67,500 direct

RUSSO THOMAS JOSEPH - Officer CFO

2021-04-02 16:41:57 -0400 2021-03-29 A 11,250 a 54,633 direct -0.4435 -5.5432 0.0 1 -5.5432 6

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ASSEMBLY BIOSCIENCES INC ASMB 2021-05-10 21:15:02 UTC -0.8263 0.8763 1000000
ASSEMBLY BIOSCIENCES INC ASMB 2021-05-10 20:45:03 UTC -0.8342 0.8842 1000000
ASSEMBLY BIOSCIENCES INC ASMB 2021-05-10 20:15:03 UTC -0.8342 0.8842 1000000
ASSEMBLY BIOSCIENCES INC ASMB 2021-05-10 19:45:03 UTC -0.8342 0.8842 1000000
ASSEMBLY BIOSCIENCES INC ASMB 2021-05-10 19:15:03 UTC -0.8342 0.8842 1000000
ASSEMBLY BIOSCIENCES INC ASMB 2021-05-10 18:45:03 UTC -0.8342 0.8842 1000000
ASSEMBLY BIOSCIENCES INC ASMB 2021-05-10 18:15:03 UTC -0.8342 0.8842 1000000
ASSEMBLY BIOSCIENCES INC ASMB 2021-05-10 17:45:02 UTC -0.8342 0.8842 1000000
ASSEMBLY BIOSCIENCES INC ASMB 2021-05-10 17:15:03 UTC -0.8342 0.8842 1000000
ASSEMBLY BIOSCIENCES INC ASMB 2021-05-10 16:45:03 UTC -0.8342 0.8842 1000000
ASSEMBLY BIOSCIENCES INC ASMB 2021-05-10 16:15:03 UTC -0.8342 0.8842 1000000
ASSEMBLY BIOSCIENCES INC ASMB 2021-05-10 15:45:03 UTC -0.8342 0.8842 1000000
ASSEMBLY BIOSCIENCES INC ASMB 2021-05-10 15:15:03 UTC -0.8342 0.8842 1000000
ASSEMBLY BIOSCIENCES INC ASMB 2021-05-10 14:45:04 UTC -0.7787 0.8287 1000000
ASSEMBLY BIOSCIENCES INC ASMB 2021-05-10 14:15:04 UTC -0.7787 0.8287 1000000
ASSEMBLY BIOSCIENCES INC ASMB 2021-05-10 13:45:04 UTC -0.7787 0.8287 1000000
ASSEMBLY BIOSCIENCES INC ASMB 2021-05-10 13:15:03 UTC -0.7787 0.8287 1000000
ASSEMBLY BIOSCIENCES INC ASMB 2021-05-10 12:45:02 UTC -0.7787 0.8287 600000
ASSEMBLY BIOSCIENCES INC ASMB 2021-05-07 22:15:03 UTC -0.7787 0.8287 600000
ASSEMBLY BIOSCIENCES INC ASMB 2021-05-07 21:45:02 UTC -0.7787 0.8287 600000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
AQR Funds- AQR Small Cap Relaxed Constraint Equity Fund ASMB -122.0 shares, $-1199.26 2019-09-30 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund ASMB -13.0 shares, $-192.79 2020-03-31 N-PORT

Elevate your investments